These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16541356)

  • 21. Selective pulmonary artery perfusion followed by blood flow occlusion: new challenge for the treatment of pulmonary malignancies.
    Grootenboers MJ; Schramel FM; van Boven WJ; Hendriks JM; van Schil PE; De Wit PE; Pasterkamp G; Folkerts G; van Putte BP
    Lung Cancer; 2009 Mar; 63(3):400-4. PubMed ID: 18657338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.
    Shepherd FA; Cormier Y; Burkes R; Evans WK; Goss G; Klimo P; Feld R; Taylor M
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-27-S8-30. PubMed ID: 9207313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weekly gemcitabine and monthly cisplatin for advanced non-small cell lung carcinoma.
    Abratt RP; Hacking DJ; Goedhals L; Bezwoda WR
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-18-S8-23. PubMed ID: 9207311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer.
    Shepherd FA; Abratt RP; Anderson H; Gatzemeier U; Anglin G; Iglesias J
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-50-S7-55. PubMed ID: 9194481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary intravascular volume can be used for dose calculation in isolated lung perfusion.
    van Putte BP; Huisman A; Hendriks JM; van Schil PE; van Boven WJ; Schramel F; Nijkamp F; Folkerts G
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):594-8. PubMed ID: 16135409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 13-cis-Retinoic acid in combination with gemcitabine in the treatment of locally advanced and metastatic pancreatic cancer--report of a pilot phase II study.
    Michael A; Hill M; Maraveyas A; Dalgleish A; Lofts F
    Clin Oncol (R Coll Radiol); 2007 Mar; 19(2):150-3. PubMed ID: 17355112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anterograde versus retrograde isolated lung perfusion with melphalan in the WAG-Rij rat.
    Romijn S; Hendriks JM; Van Putte BP; Weyler J; Guetens G; De Boeck G G; De Bruijn EA; Van Schil PE
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1083-5. PubMed ID: 15896622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolated lung perfusion with doxorubicin prolongs survival in a rodent model of pulmonary metastases.
    Abolhoda A; Brooks A; Nawata S; Kaneda Y; Cheng H; Burt ME
    Ann Thorac Surg; 1997 Jul; 64(1):181-4. PubMed ID: 9236357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I study of gemcitabine given weekly as a short infusion for non-small cell lung cancer: results and possible immune system-related mechanisms.
    Levitt ML; Kassem B; Gooding WE; Miketic LM; Landreneau RJ; Ferson PF; Keenan R; Yousem SA; Lindberg CA; Trenn MR; Ponas RS; Tarasoff P; Sabatine JM; Friberg D; Whiteside TL
    Lung Cancer; 2004 Mar; 43(3):335-44. PubMed ID: 15165093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
    Cobo Dols M; Villar Chamorro E; Alés Díaz I; Gil Calle S; Alcalde García J; Gutiérrez Calderón V; Carabantes Ocón F; Montesa Pino A; Bretón García JJ; Benavides Orgaz M
    Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gemcitabine-induced systemic capillary leak syndrome.
    De Pas T; Curigliano G; Franceschelli L; Catania C; Spaggiari L; de Braud F
    Ann Oncol; 2001 Nov; 12(11):1651-2. PubMed ID: 11822767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine.
    Gordon N; Kleinerman ES
    J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):189-96. PubMed ID: 20528149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter Phase II Clinical Trial of Isolated Lung Perfusion in Patients With Lung Metastases.
    Beckers PAJ; Versteegh MIM; Van Brakel TJ; Braun J; Van Putte B; Maat APWM; Vergauwen W; Rodrigus I; Den Hengst W; Lardon F; De Bruijn E; Guetens G; De Boeck G; Gielis JF; Lauwers P; Denissen L; Hendriks JMH; Van Schil PE
    Ann Thorac Surg; 2019 Jul; 108(1):167-174. PubMed ID: 30951699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gemcitabine in locally advanced and metastatic non-small cell lung cancer: the Central European phase II study.
    Zatloukal P; Kanitz E; Magyar P; Jassem J; Krzakowski M; Pawlicki M; Petruzelka L; Chovan L; Pesek M; Janko C; Krejcy K
    Lung Cancer; 1998 Dec; 22(3):243-50. PubMed ID: 10048477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer.
    Okusaka T; Ishii H; Funakoshi A; Yamao K; Ohkawa S; Saito S; Saito H; Tsuyuguchi T
    Cancer Chemother Pharmacol; 2006 May; 57(5):647-53. PubMed ID: 16142487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer.
    Manegold C; Drings P; von Pawel J; Ricci S; Dornoff W; van Walree N; ten Bokkel Huinink W; Chemaissani A; Stahel P; Bergman B; Wagenius G; Sederholm C; Mattson K; Liippo K; Kellokumpu-Lehtinen P
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-13-S8-17. PubMed ID: 9207310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The emerging role of gemcitabine in lung cancer.
    Bunn PA
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-1. PubMed ID: 9207307
    [No Abstract]   [Full Text] [Related]  

  • 39. Results of a phase II trial of gemcitabine in patients with non-small-cell lung cancer and a performance status of 2.
    Neubauer MA; Reynolds CH; Joppert MG; Whitaker T; Ghaddar H; Marsland TA; Asmar L
    Clin Lung Cancer; 2005 Jan; 6(4):245-9. PubMed ID: 15694017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase I study of gemcitabine given via intrahepatic pump for primary or metastatic hepatic malignancies.
    Tse AN; Wu N; Patel D; Haviland D; Kemeny N
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):935-44. PubMed ID: 19221752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.